BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Identify dividend ETFs with the cheapest expense ratios without sacrificing reliability. This guide helps distinguish leaders in low-cost access.
27,552 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Investors watch WWDC 2026 with high expectations as Apple readies a major AI push. This preview outlines what’s at st...
GameStop posts a strong Q1 FY26 beat and authorizes a $2 billion buyback, signaling a pivot to a cash-rich model. The...
The University of Wisconsin System fired its president in a unanimous vote after a brief closed-door meeting, leaving...
Investors chasing steady monthly income via QYLD face a trade-off: the cost of covered-call income can outpace Nasdaq...
Alphabet is shifting from relying on Broadcom to building its own AI chips, aiming to feed GOOG’s hyperscale cloud wh...
A U.S. startup says its graphene-based, non-lithium energy storage solution is safer and faster to deploy, reporting ...
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Investors are watching whether Alphabet can become the most valuable company by turning Google Cloud into a high-marg...
Walmart and Costco sit at opposite ends of the retail revenue spectrum, yet their growth stories diverge in meaningfu...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...
AGNT, Inc. has completed its corporate transformation, changing its name and moving its domicile to Texas. The move i...